Clinical Trial: Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: An Randomized and Controlled Study of Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
Brief Summary: To investigate the therapy effect and security of oxaliplatin and fluorouracil on with or without concomitant vascular invasion and extrahepatic metastases unresectable advanced primary liver cancer
Detailed Summary:
Sponsor: Zhu Xu
Current Primary Outcome: Progression-free survival (PFS) [ Time Frame: three years ]
Original Primary Outcome: Same as current
Current Secondary Outcome: overall survival (OS) [ Time Frame: three years ]
Original Secondary Outcome: Same as current
Information By: Beijing Cancer Hospital
Dates:
Date Received: September 22, 2015
Date Started: January 2015
Date Completion: December 2017
Last Updated: September 22, 2015
Last Verified: July 2015